Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Yellow Fever Vaccine · Yf-Vax

Vaccine (Live attenuated vaccine) · Immune activation · developed by Sanofi Vaccines US

Approved FDA, Dec 1999
SNY Developer
1 Registered trials

What is Yellow Fever Vaccine?

YF-VAX is a live, attenuated viral vaccine against yellow fever, a disease endemic to parts of Africa and South America. It is given as a subcutaneous injection of powder and diluent for suspension, and is studied for yellow fever immunization.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Yf-Vax
Drug type
Vaccine (Live attenuated vaccine)
Mechanism
Immune activation
Therapy area
Infectious disease
Developer
Sanofi Vaccines US Inc. (SNY)
FDA status
Approved as Yf-Vax (December 9, 1999), BLA103915

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07103148 Phase 3 Yellow Fever Immunization Active not recruiting SNY

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Yellow Fever Immunization

More from Sanofi Vaccines US

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the SNY page.

Follow SNY, the company behind Yellow Fever Vaccine

See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SNY catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.